MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip

• Үндсэн зохиолчид: Li Gao (Зохиогч), Shi-bai Yan (Зохиогч), Jie Yang (Зохиогч), Jin-liang Kong (Зохиогч), Ke Shi (Зохиогч), Fu-chao Ma (Зохиогч), Lin-zhen Huang (Зохиогч), Jie Luo (Зохиогч), Shu-ya Yin (Зохиогч), Rong-quan He (Зохиогч), Xiao-hua Hu (Зохиогч), Gang Chen (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2020-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Background MiR-182-5p, a cancer-related microRNA (miRNA), modulates tumorigenesis and patient outcomes in various human malignances. This study interroted the clinicopathological significance and molecular mechanisms of miR-182-5p in non-small cell lung cancer (NSCLC). Methods The clinical...